Literature DB >> 28716497

Dual-energy X-ray Absorptiometry.

Rajesh K Jain1, Tamara Vokes2.   

Abstract

Bone mineral density (BMD) measurement by dual-energy X-ray absorptiometry (DXA) is the most commonly used method to assess fracture risk. DXA utilizes two different energy X-rays to calculate BMD and, by comparison to a young normative database, the T-score. In 1994, the World Health Organization defined osteoporosis based on T-score, changing the paradigm of the field and forever placing DXA measurements in the center of osteoporosis diagnosis. Since then, many large studies have demonstrated the predictive value of BMD by DXA-for every standard deviation decline in BMD, there is a relative risk of 1.5-2.5 for fracture. This predictive ability is similar to how blood pressure can predict myocardial infarction. Limitations of DXA are also important to consider. While BMD by DXA can identify those at risk, there is a significant overlap in the BMD of patients who will and will not fracture. Special considerations are also needed in men and ethnic minority groups. These groups may have different bone size, thus affecting the normative range of BMD, and/or distinct bone structure that affect the association between BMD and fractures. Finally, BMD can be affected by positioning errors or artifacts, including osteoarthritis, fracture, and jewelry. Of course, DXA has tremendous strengths as well-namely its wide availability, its low radiation exposure, and a large body of evidence that relate DXA measurements to fracture risk. For these reasons, DXA remains the cornerstone of fracture assessment now and for the foreseeable future.
Copyright © 2017 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DXA; ethnicity; fracture; osteoporosis

Mesh:

Year:  2017        PMID: 28716497     DOI: 10.1016/j.jocd.2017.06.014

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  25 in total

1.  Comparison of novel DXA system, Shimazu SONIALVISION G4, with GE-Lunar PRODIGY.

Authors:  Toki Takemoto; Takeshi Oguchi; Koji Oda
Journal:  J Bone Miner Metab       Date:  2021-06-11       Impact factor: 2.626

Review 2.  Dual-energy X-ray absorptiometry bone densitometry in pediatrics: a practical review and update.

Authors:  Hedieh Khalatbari; Larry A Binkovitz; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2020-08-28

3.  Development of an open-source measurement system to assess the areal bone mineral density of the proximal femur from clinical CT images.

Authors:  Keisuke Uemura; Yoshito Otake; Masaki Takao; Hiroki Makino; Mazen Soufi; Makoto Iwasa; Nobuhiko Sugano; Yoshinobu Sato
Journal:  Arch Osteoporos       Date:  2022-01-17       Impact factor: 2.617

4.  Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study.

Authors:  Xinshui Wang; Ruoling Teng; Fenfen Liu; Ping Liu; Yujiao Yang
Journal:  Gland Surg       Date:  2022-02

5.  Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.

Authors:  Juliano Henrique Borges; Daniel Minutti de Oliveira; Sofia Helena Valente de Lemos-Marini; Bruno Geloneze; Gil Guerra-Júnior; Ezequiel Moreira Gonçalves
Journal:  Osteoporos Int       Date:  2021-08-18       Impact factor: 4.507

6.  Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women.

Authors:  E How Shing Koy; A Amouzougan; E Biver; R Chapurlat; T Chevalley; S L Ferrari; A Fouilloux; H Locrelle; H Marotte; M Normand; R Rizzoli; L Vico; T Thomas
Journal:  Osteoporos Int       Date:  2021-10-12       Impact factor: 4.507

Review 7.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review.

Authors:  Carmelo Messina; Gabriele Maffi; Jacopo Antonino Vitale; Fabio Massimo Ulivieri; Giuseppe Guglielmi; Luca Maria Sconfienza
Journal:  Quant Imaging Med Surg       Date:  2018-02

8.  Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.

Authors:  David A Bushinsky; Paolo Raggi; Jordi Bover; Markus Ketteler; Antonio Bellasi; Mariano Rodriguez; Smeeta Sinha; Rekha Garg; Joan Perelló; Alex Gold; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-07       Impact factor: 8.237

Review 9.  Hidden hypercortisolism: a too frequently neglected clinical condition.

Authors:  L Giovanelli; C Aresta; V Favero; M Bonomi; B Cangiano; C Eller-Vainicher; G Grassi; V Morelli; F Pugliese; A Falchetti; L Gennari; A Scillitani; L Persani; I Chiodini
Journal:  J Endocrinol Invest       Date:  2021-01-04       Impact factor: 4.256

10.  Osteoporosis and Endplate Damage Correlation Using a Combined Approach of Hounsfield Unit Values and Total Endplate Scores: A Retrospective Cross-Sectional Study.

Authors:  Chenyang Zhuang; Zixiang Wang; Weisin Chen; Bo Tian; Juan Li; Hong Lin
Journal:  Clin Interv Aging       Date:  2021-07-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.